Journal article icon

Journal article

Donor template delivery by recombinant adeno-associated virus for the production of knock-in mice

Abstract:
Abstract Background The ability of recombinant adeno-associated virus to transduce preimplantation mouse embryos has led to the use of this delivery method for the production of genetically altered knock-in mice via CRISPR-Cas9. The potential exists for this method to simplify the production and extend the types of alleles that can be generated directly in the zygote, obviating the need for manipulations of the mouse genome via the embryonic stem cell route. Results We present the production data from a total of 13 genetically altered knock-in mouse models generated using CRISPR-Cas9 electroporation of zygotes and delivery of donor repair templates via transduction with recombinant adeno-associated virus. We explore the efficiency of gene targeting at a total of 12 independent genetic loci and explore the effects of allele complexity and introduce strategies for efficient identification of founder animals. In addition, we investigate the reliability of germline transmission of the engineered allele from founder mice generated using this methodology. By comparing our production data against genetically altered knock-in mice generated via gene targeting in embryonic stem cells and their microinjection into blastocysts, we assess the animal cost of the two methods. Conclusions Our results confirm that recombinant adeno-associated virus transduction of zygotes provides a robust and effective delivery route for donor templates for the production of knock-in mice, across a range of insertion sizes (0.9–4.7 kb). We find that the animal cost of this method is considerably less than generating knock-in models via embryonic stem cells and thus constitutes a considerable 3Rs reduction
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s12915-024-01834-z

Authors

More by this author
Role:
Author
ORCID:
0009-0006-7834-7962
More by this author
Role:
Author
ORCID:
0009-0001-2730-3349
More by this author
Role:
Author
ORCID:
0009-0006-1622-0237
More by this author
Role:
Author
ORCID:
0000-0001-6601-4382
More by this author
Role:
Author
ORCID:
0009-0002-4371-7100


More from this funder
Funder identifier:
10.13039/100010269
Grant:
CC0199
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
CC0199
More from this funder
Funder identifier:
10.13039/501100000289
Grant:
CC0199
More from this funder
Funder identifier:
10.13039/100010438


Publisher:
BioMed Central
Journal:
BMC Biology More from this journal
Volume:
22
Issue:
1
Pages:
26-26
Article number:
26
Publication date:
2024-02-02
DOI:
EISSN:
1741-7007
ISSN:
1741-7007


Language:
English
Keywords:
Pubs id:
1620304
Local pid:
pubs:1620304
Source identifiers:
W4392785481
Deposit date:
2026-06-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP